Prior fluconazole exposure as an independent risk factor for fluconazole resistant candidosis in HIV positive patients: A case-control study

Genitourinary Medicine

Volumn 73, Issue 6, 1997, Pages 471-474

  Jonathan, I ^a   Cartledge, D ^a   Midgley, Jennifer ^a   Gazzard, Brian G ^a  

^a Chelsea and Westminster Foundation Trust   (United Kingdom)

Author keywords

Candidosis; Fluconazole; HIV; Risk factor

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDIASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THRUSH;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DRUG RESISTANCE, MICROBIAL; FLUCONAZOLE; HUMANS; RISK FACTORS;

EID: 0031423595     PISSN: 02664348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Boken DJ, Swindells S, Rinaldi MG. Fluconazole resistant Candida albicans in HIV infection. In: Proceedings of the ninth international conference on AIDS, Berlin, 1993. Abstract PO-B08-1358.
2. Fox R, Neal KR, Leen CLS, Ellis ME, Mandai BK. Fluconazole resistant Candida in AIDS (letter). J Infect 1991;22:201-2.
3. Kitchen VS, Savage M, Harris JRW. Candida albicans resistance in AIDS (letter). J Infect 1991;22:204-5.
4. Smith D, Boag F, Midgley J, Gazzard BG. Fluconazole-resistant Candida in AIDS (letter). J Infect 1991;23:345-6.
5. Odds FC. Antifungal susceptibility testing of Candida species by relative growth measurement at single concentrations of amifungal agents. Antimicrob Agents Chemother 1992;36:1727-37.
6. Cartledge JD, Midgley J, Gazzard BG. Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis. J Antimkrob Chemother 1996;37:275-83.
7. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HlV-infected patients receiving prolonged fiuconazole therapy for oral candidosis. J Antimkrob Chemother 1995;35:103-14.
8. Nelson MR, Fisher M, Cartledge J, Rogers T, Gazzard BG. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HFV infection. AIDS 1994;8:651-4.
9. Powderly WG, Finkelstein DM, Feinberg J, Frame P, He W, van der Herst C, et al. A randomised trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995;332:700-5.